FI
FI · FI · FI-REL-REL60987
Celldemic
ATC J07BB02
Last synced from Fimea (Finland) on
Identification
ManufacturerSeqirus Netherlands B.V.
CountryFI (FI)
ATC codeJ07BB02
Dispensing—
ReimbursedNo
SourceFimea (Finland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"ddd": null,
"form": "injektioneste, suspensio, esitäytetty ruisku",
"route": "Lihakseen",
"ddd_unit": null,
"strength": "7.5 mikrog HA / 0.5 ml",
"atc_label": "influenssarokote, puhdistettu antigeeni",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/24/1806/001",
"fimea_rel_id": "REL60987",
"authorised_at": "2024-04-19"
}Related drugs
Other records sharing ATC code J07BB02.
- BEAdjupanrixGlaxoSmithKline Biologicals
- FIAdjupanrixGlaxoSmithKline Biologicals SA
- PLAdjupanrixGlaxoSmithKline Biologicals S.A.
- ISAdjupanrixGlaxoSmithKline Biologicals S.A.*
- DKAdjupanrixGlaxoSmithKline Biologicals S.A.
- CZADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IEAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NLAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Access this data programmatically
Query Celldemic and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.